Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …

Background Few studies have evaluated real-world treatment patterns and survival in
follicular lymphoma (FL). This study evaluated these outcomes among newly diagnosed …

High-dose therapy followed by autologous stem cell transplantation is widely accepted as
salvage therapy for patients with relapsed aggressive lymphoma. In the pre-rituximab era …

Key points and recommendations Follicular lymphoma is a subgroup of non-Hodgkin
lymphomas of B-cell origin, characterized by a pattern of remissions and continued relapses …

Abstract Disease Overview Follicular lymphoma (FL) is generally an indolent B cell
lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by …

Background Novel therapies for relapsed or refractory follicular lymphoma are commonly
evaluated in single-arm studies without formal comparison with other treatments or historical …

Background Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …

High-dose chemotherapy supported by autologous stem cell transplantation (HDT/ASCT)
has contributed to modify the natural history of follicular lymphoma (FL); however, an overall …

Autologous stem cell transplantation (ASCT) as first-line therapy for follicular lymphoma (FL)
remains controversial. The multicenter study randomized 172 patients with untreated FL for …

High-dose therapy and autologous stem cell transplantation (HDT/ASCT) is an effective
salvage treatment for eligible patients with follicular lymphoma (FL) and early progression of …